We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Portable Suitcase Mini-Laboratory for Rapid Detection of SARS-CoV-2 Provides Test Results as Good as PCR Test in Real Time

By LabMedica International staff writers
Posted on 12 Feb 2021
Print article
Image: Portable Suitcase Mini-Laboratory for Rapid Detection of SARS-CoV-2 (Photo courtesy of Dr Ahmed Abd El Wahed)
Image: Portable Suitcase Mini-Laboratory for Rapid Detection of SARS-CoV-2 (Photo courtesy of Dr Ahmed Abd El Wahed)
A portable suitcase mini-laboratory for the rapid detection of SARS-CoV-2 provides test results that are almost as good as a PCR test and almost in real time, according to new research.

In the first study of the suitcase laboratory at Leipzig University (Leipzig, Germany) in cooperation with several African universities, researchers used genome analysis (RPA method, recombinase polymerase amplification) to detect an infection with SARS-CoV-2 almost in real time, with an accuracy of 94%. The method that will now be used to conduct coronavirus testing has already been successfully evaluated for several other infectious diseases.

The suitcase is a small, mobile laboratory equipped with a diagnostic device, solar power supply, various reagents, some reference RNA extracts and rubber gloves. The compact case could provide rapid coronavirus test results in regions of Africa where testing facilities and medical infrastructure fall far short of European standards. Infected people can thus be identified and isolated more quickly. This is an important and life-saving measure in countries that may have to wait a long time for vaccines, and will contribute to bringing the COVID-19 pandemic under control.

For COVID-19 diagnosis, the mobile suitcase lab has already been implemented in Egypt, Ghana, and Senegal, as well as in five other African countries. Results will now be evaluated in further studies. Specifically, the exact performance of the developed SARS-CoV-2 RPA assays will be determined and compared to PCR assays. If the results are comparable, as the preliminary data seem to suggest, the suitcase laboratory could soon be increasingly used in the clinical field to determine SARS-CoV-2.

“With this tool, a so-called RPA test can be done directly on site, even in the most remote areas. It takes only 15 minutes to get a result,” said virologist Dr Ahmed Abd El Wahed from the Institute of Animal Hygiene and Veterinary Public Health, who is leading the study at Leipzig University. “A saliva sample or a nasal swab is sufficient for the test and all reagents can be used at room temperature.”

Related Links:
Leipzig University

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: A massive study has identified new biomarkers for renal cancer subtypes, improving diagnosis and treatment (Photo courtesy of Jessica Johnson)

Novel Biomarkers to Improve Diagnosis of Renal Cell Carcinoma Subtypes

Renal cell carcinomas (RCCs) are notably diverse, encompassing over 20 distinct subtypes and generally categorized into clear cell and non-clear cell types; around 20% of all RCCs fall into the non-clear... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: The T-SPOT.TB test is now paired with the Auto-Pure 2400 liquid handling platform for accurate TB testing (Photo courtesy of Shutterstock)

Integrated Solution Ushers New Era of Automated Tuberculosis Testing

Tuberculosis (TB) is responsible for 1.3 million deaths every year, positioning it as one of the top killers globally due to a single infectious agent. In 2022, around 10.6 million people were diagnosed... Read more